Acute Myelogenous Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Not yet recruiting
  • Myelofibrosis
  • Acute Myelogenous Leukemia
  • TBX-2400
  • Zagreb, Croatia
  • +1 more
2022-01-11
Jan 11, 2022
F
Recruiting
  • Acute Myelogenous Leukemia
  • B-cell Lymphoma
  • Phoenix, Arizona
  • +5 more
2021-12-22
Dec 22, 2021
A
Terminated
  • Acute Myelogenous Leukemia in Relapse
  • +4 more
  • Tucson, Arizona
  • +12 more
2022-01-06
Jan 6, 2022
J
Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • Miami, Florida
    University of Miami
2021-12-07
Dec 7, 2021
V
Active, not recruiting
  • Hodgkin's Lymphoma
  • +17 more
  • mycophenolate mofetil
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
2021-12-21
Dec 21, 2021
N
Enrolling by invitation
  • Acute Lymphoblastic Leukemia
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-12-15
    Dec 15, 2021
    U
    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Rochester, New York
      University of Rochester
    2021-12-08
    Dec 8, 2021
    C
    Recruiting
    • Acute Lymphoblastic Leukemia
    • +7 more
    • Duarte, California
    • +10 more
    2021-12-02
    Dec 2, 2021
    M
    Completed
    • Acute Lymphocytic Leukemia
    • +6 more
    • Haploidentical Bone Marrow Transplant
    • Double Umbilical Cord Blood Transplant
    • Birmingham, Alabama
    • +38 more
    2021-11-02
    Nov 2, 2021
    W
    Recruiting
    • Acute Myelogenous Leukemia
    • +9 more
      • Winston-Salem, North Carolina
        Wake Forest Baptist Health
      2021-11-23
      Nov 23, 2021
      M
      Recruiting
      • Related Donors Donating PBSC to a Family Member
      • +4 more
      • MGTA-145
      • Plerixafor
      • Duarte, California
      • +9 more
      2021-11-22
      Nov 22, 2021
      D
      Recruiting
      • Acute Myelogenous Leukemia
      • Boston, Massachusetts
      • +1 more
      2021-11-15
      Nov 15, 2021
      D
      Recruiting
      • Acute Myelogenous Leukemia
      • DC/AML Fusion Vaccine
      • Observation
      • Atlanta, Georgia
      • +4 more
      2021-11-15
      Nov 15, 2021
      N
      Active, not recruiting
      • Acute Myelogenous Leukemia
      • Myelodysplastic Syndrome
      • Gemtuzumab Ozogamicin
      • Valhalla, New York
        New York Medical College
      2021-11-11
      Nov 11, 2021
      N
      Active, not recruiting
      • Acute Myelogenous Leukemia
      • Myelodysplastic Syndrome
      • Gemtuzumab Ozogamicin
      • Valhalla, New York
        New York Medical College
      2021-11-11
      Nov 11, 2021
      N
      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • +4 more
      • Valhalla, New York
      • +1 more
      2021-10-29
      Oct 29, 2021
      N
      Active, not recruiting
      • Mucopolysaccharidosis I
      • +15 more
      • Human Placental Derived Stem Cell
      • Denver, Colorado
      • +2 more
      2021-10-29
      Oct 29, 2021
      U
      Active, not recruiting
      • Leukemia
      • +2 more
      • Gainesville, Florida
        UF Health Shands Cancer Hospital
      2021-10-28
      Oct 28, 2021
      M
      Completed
      • Acute Myelogenous Leukemia
      • +4 more
      • Single Umbilical Cord Blood Unit Transplant
      • +6 more
      • Birmingham, Alabama
      • +37 more
      2021-10-13
      Oct 13, 2021
      M
      Active, not recruiting
      • Acute Myelogenous Leukemia
      • Rochester, Minnesota
      • +1 more
      2021-09-21
      Sep 21, 2021
      X
      Recruiting
      • Acute Myelogenous Leukemia
      • +3 more
      • XmAb14045
      • Jacksonville, Florida
      • +8 more
      2021-09-21
      Sep 21, 2021
      G
      Active, not recruiting
      • High-risk Myelodysplastic Syndromes
      • +3 more
      • GTB-3550 TriKE® Phase I
      • GTB-3550 TriKE® Phase II
      • Minneapolis, Minnesota
      • +1 more
      2021-09-15
      Sep 15, 2021